BNO 5.26% 20.0¢ bionomics limited

Ann: Commencement of BNC210 Phase 2 Agitation Trial, page-28

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 912 Posts.
    lightbulb Created with Sketch. 95
    Weird that Edison doesn't model any value for BNC 210 for GAD, even though we've had a successful Phase II trial. Most of the NPV in their model is for PTSD, and they give that a 30% chance of success with potential Launch in 2022.
 
watchlist Created with Sketch. Add BNO (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.